Previous Article | Next Article 
Journal of Bacteriology, February 2000, p. 993-1000, Vol. 182, No. 4
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Detergent-Soluble Maltose Transporter Is
Activated by Maltose Binding Protein and Verapamil
Ronit
Reich-Slotky,
Cynthia
Panagiotidis,
Moraima
Reyes, and
Howard A.
Shuman*
Department of Microbiology, College of
Physicians & Surgeons, Columbia University, New York, New York 10032
Received 21 October 1999/Accepted 23 November 1999
 |
ABSTRACT |
The maltose transporter FGK2 complex of Escherichia
coli was purified with the aid of a glutathione
S-transferase molecular tag. In contrast to the
membrane-associated form of the complex, which requires liganded
maltose binding protein (MBP) for ATPase activity, the purified
detergent-soluble complex exhibited a very high level of ATPase
activity. This uncoupled activity was not due to dissociation of the
MalK ATPase subunit from the integral membrane protein MalF and MalG
subunits. The detergent-soluble ATPase activity of the complex could be
further stimulated by wild-type MBP but not by a signaling-defective
mutant MBP. Wild-type MBP increased the Vmax of
the ATPase 2.7-fold but had no effect on the Km
of the enzyme for ATP. When the detergent-soluble complex was
reconstituted in proteoliposomes, it returned to being dependent on MBP
for activation of ATPase, consistent with the idea that the structural
changes induced in the complex by detergent that result in activation
of the ATPase are reversible. The uncoupled ATPase activity resembled
the membrane-bound activity of the complex also with respect to
sensitivity to NaN3, as well as a mercurial, p-chloromercuribenzosulfonic acid. Verapamil, a compound
that activates the ATPase activity of the multiple drug resistance P-glycoprotein, activated the maltose transporter ATPase as well. The
activation of this bacterial transporter by verapamil suggests that a
structural feature that is conserved among both eukaryotic and
prokaryotic ATP binding cassette transporters is responsible for this activation.
 |
INTRODUCTION |
The membrane components of the
maltose transport system of Escherichia coli catalyze the
intracellular accumulation of malto-oligosaccharides at the expense of
ATP hydrolysis (5). They comprise two integral membrane
proteins, MalF and MalG, and two copies of a cytoplasmic ATP binding
subunit, MalK (36). In addition to these components directly
involved in substrate translocation, there is a periplasmic maltose
binding protein (MBP) and a maltoporin (LamB) located in the outer
membrane (5). This transporter is a member of the ATP
binding cassette (ABC) superfamily, and the MalK sequence shares
significant similarity with the sequences of several other prokaryotic
and eukaryotic transport proteins that belong to this family.
The FGK2 complex has been extensively characterized both genetically
and biochemically. In most instances, the transporter has been studied
either in whole cells, in subcellular vesicles, or in some cases
following purification and reconstitution, in proteoliposomes. In all
cases, the transport and ATPase activities of the FGK2 complex have
been shown to be strongly dependent on MBP. Efforts to study the
molecular basis of these transport and ATPase activities have been
limited by the need to reconstitute the transporter in proteoliposomes.
It has been generally assumed that a detergent-soluble form of this and
other ABC transporters would not be a useful model for studying their
molecular properties. Indeed, several publications have reported that
detergent solubilization rendered both the maltose and histidine
transporters inactive (7, 21). An alternative approach has
been to study the water-soluble ABC subunit (e.g., MalK or HisP) in
isolation (28, 39). Although these studies have provided
information about the responses of the proteins to nucleotides, they
cannot address the effects of signaling by their respective periplasmic
binding proteins.
In the work described here, we found evidence that, in contrast to
these previous studies, the detergent-soluble form of the wild-type
FGK2 transporter is active and retains important characteristics, such
as the ability to respond to signaling by the periplasmic MBP. In
addition, we provide a quantitative comparison of the activities of (i)
the reconstituted membrane-bound form of the purified wild-type
complex, (ii) the detergent-soluble form of the wild-type and uncoupled
mutant complexes, and (iii) the isolated MalK subunit. We also report
that this bacterial periplasmic binding protein-dependent ABC
transporter responds to verapamil, a drug that is known to reverse the
MDR phenotype by uncoupling ATP hydrolysis from drug efflux
(15). These results indicate that the structural features
required for verapamil binding and activity are broadly conserved among
prokaryotic and eukaryotic ABC transporters with diverse functions.
 |
MATERIALS AND METHODS |
Strains and plasmids.
All of the strains and plasmids used
in this study are summarized in Table 1.
Strain NT169 was used as a host for expression of the maltose complex,
HS3309 was used as a host for expression of wild-type MBP and
signaling-defective mutant MBP, and X90(DE3) (38) was used
as a host for expression of the His6-MalK protein.
Construction of plasmids pMR41 and pMR31.
Plasmid pMR41
(ampicillin resistance [Ampr]) contains both the
gst-malG fusion and the malK genes individually
under control of the Ptac promoter. To create the
gst-malG fusion, a BamHI restriction site was
introduced immediately upstream from the ATG of the malG coding sequence in plasmid pYSF12. From this plasmid, a
BamHI-BsaAI fragment containing the entire
malG coding sequence was ligated into plasmid pGEX-2T
(Pharmacia Biotech), which had been digested with BamHI and
SmaI, to create plasmid pCP13. A BamHI fragment derived from plasmid pMR11 (32) containing the wild-type
malK gene under control of the Ptac promoter was
introduced into pCP13 by first filling in the BamHI sticky
ends and then ligating the blunt-end fragment into the EcoRV
site within the lacIq gene of plasmid pCP13.
Plasmid pMR31 contains the malF gene under control of the
Ptac promoter on a derivative of pACYC184 (chloramphenicol
resistance) and is compatible with pMR41. It was constructed by
ligation of an NcoI-BclI fragment containing the
malF gene into a derivative of pACYC184 (pLAW304)
(40).
Overproduction of MalK, MalF, and GST-MalG.
NT169 cells were
transformed with plasmids carrying the malF gene (pMR31) and
the malK and gst-malG genes (pMR41). All genes were under control of the Ptac promoter. The bacteria were
grown at 28°C to logarithmic phase in LB medium (10 g of tryptone per liter, 5 g of yeast extract per liter, 10 g of NaCl per
liter) containing 100 µg of ampicillin per milliliter and 25 µg of
chloramphenicol per ml. After induction with 1 mM
isopropyl-
-D-thiogalactopyranoside (IPTG) for 4 h,
the cells were pelleted and membranes were prepared as described
elsewhere (9). Briefly, the cell pellet was resuspended in
20 mM Tris-HCl (pH 7)-5 mM MgCl2-1 mM EDTA-50 mM
NaCl-10 µg of phenylmethylsulfonyl fluoride per ml-1 mM
dithiothreitol (DTT). The cells were passed twice through a French
press at 16,000 lb/in2, and the unbroken cells were removed
by centrifugation at 3,000 × g for 10 min. The
supernatant fraction was centrifuged at 100,000 × g
for 1 h at 4°C. The pellet was resuspended in the same buffer to
a protein concentration of 20 mg/ml and stored at
80°C.
Solubilization of membrane protein.
Thawed membranes were
solubilized in 20 mM Tris-HCl (pH 7)-5 mM MgCl2-10 µg
of phenylmethylsulfonyl fluoride per ml-1 mM DTT-20% glycerol-1.6%
dodecyl maltoside to a final protein concentration of 4 mg/ml. After 30 min of incubation on ice, the solubilized membranes were centrifuged at
100,000 × g for 1 h at 4°C and the supernatant
was removed for purification of the maltose transporter on an affinity column.
Affinity purification of the maltose transporter complex.
A
2-ml volume of glutathione agarose (Pharmacia Biotech) resin was added
to 10 ml of solubilized membrane supernatant and kept for 4 h at
4°C. The resin was transferred to a column and washed with 50 mM
Tris-HCl (pH 8)-5 mM MgCl2-1 mM DTT-10%
glycerol-0.01% dodecyl maltoside. To cleave the glutathione
S-transferase (GST) from MalG, biotinylated thrombin
(Novagen) was added to the resin, the mixture was subjected to 18 h of incubation at 4°C, and then the complex was eluted from the
column. The eluted complex was incubated with 50 µl of a streptavidin
agarose suspension for 30 min and then centrifuged for 5 min at
1,000 × g through a spin filter centrifuge tube to
remove the thrombin-containing beads. If thrombin was not used to
cleave the GST-MalG hybrid, the GST-MalG-containing complex was eluted
with the same buffer containing 10 mM glutathione.
Assay of ATP hydrolysis.
ATP hydrolysis was measured as
described elsewhere (19). Briefly, the purified complex (5 µg/ml) was added to a solution of 40 mM Tris-HCl (pH 7)-4 mM
MgCl2-5% glycerol-0.01% dodecyl maltoside. ATP was
added to a final concentration of 4 mM, and the reaction mixture was
incubated in a 37°C bath. Aliquots of 20 µl were removed after 0 to
30 min into 160 µl of 0.033% malachite green in 1 N HCl. After 1 min, the reaction was stopped by addition of 20 µl of 34% citric
acid and the A650 was read. When doing the assay
in the presence of large amounts of protein, we used a variation of the
method as described before (6). We established that the
assay was linear over time and with respect to the concentration of the
added complex up to 25 µg/ml. When added to ATPase assays, MBP was
always saturated with maltose unless otherwise specified.
Overproduction and purification of MBP.
MBP was purified by
affinity chromatography as described before (24). Briefly,
fresh transformants of HS3309 were grown for 18 h in Terrific
Broth medium (12 g of tryptone per liter, 24 g of yeast extract
per liter, 0.4% glycerol, 2.31 g of
KH2PO4, 12.54 g of
K2HPO4 per liter), and the periplasmic fraction
was loaded onto an amylose column. After washing with 50 mM Tris-HCl (pH 7.5), the purified MBP was eluted with the same buffer containing 20 mM maltose. A Centricon 30 concentrator (Amicon) was used to concentrate the purified MBP and to wash out the excess maltose.
Expression and purification of His6-MalK
protein.
Expression and purification of His6-MalK was
done as described before (30). Briefly, the
his6-malK gene (pCP97) was transformed into
strain X90/(DE3), which was grown to logarithmic phase in Terrific
Broth medium and induced for 1 h with 1 mM IPTG. The cells were
pelleted, resuspended in 10 mM Tris-HCl (pH 8)-200 mM NaCl-10%
glycerol and passed twice through a French press at 16,000 lb/in2. The soluble fraction was recovered after a 30-min
spin at 15,000 rpm in the ss-34 rotor of a Sorvall Re-5B centrifuge,
added to Ni-nitrilotriacetic acid-agarose (QIAGEN), and incubated for
1 h at 4°C. The resin was transferred to a column and washed
with 10 mM Tris-HCl (pH 8)-500 mM NaCl-20% glycerol. The
His6-MalK protein was eluted in the same buffer containing
250 mM imidazole.
Reconstitution of the purified complex into proteoliposomes.
The dilution procedure described by Racker et al. (31) was
used to reconstitute the purified maltose transporter into
proteoliposomes. Dry, crude E. coli phospholipids (Avanti
Polar Lipid, Inc.) were resuspended to a final concentration of 50 mg/ml in 50 mM Tris-HCl (pH 8)-2 mM 2-mercaptoethanol and stored at
80°C under nitrogen until use. Aliquots were thawed and sonicated
to clarity in a bath sonicator.
Typically, 100 µl of sonicated lipids was mixed with 450 µl of the
purified complex and with or without 5 mg of MBP per ml and incubated
on ice for 15 min. The mixture was then diluted into 25 ml of 50 mM
Tris (pH 7)-1 mM DTT. Proteoliposomes were isolated by centrifugation
at 100,000 × g for 1 h at 4°C and resuspended in 250 µl of 50 mM Tris-HCl (pH 7)-1 mM DTT.
 |
RESULTS |
Overproduction and purification of FGK2 complex.
We used two
compatible plasmids to express the transport complex. One plasmid,
pMR31, encodes resistance to chloramphenicol and the MalF protein under
control of the Ptac promoter on a P15A replicon. The other
plasmid, pMR41, encodes ampicillin resistance, as well as the MalK
protein and a hybrid GST-MalG protein, both under control of separate
Ptac promoters. The GST-MalG hybrid protein retains the
ability to participate in active transport. The fused
gst-malG gene complements a malG null mutation
(data not shown). In addition, the reconstituted complex containing the
GST-MalG protein exhibited both transport and ATPase activities (C. Panagiotidis, unpublished results). These plasmids were introduced into
strain NT169, which lacks the entire malB region and
supplies the LacI repressor. The transformants were grown to
logarithmic phase, and synthesis of the transport complex was induced
by IPTG. Following harvesting of the cells and lysis in a French press, a crude membrane fraction was prepared and stored at
80°C. Aliquots of the membrane preparation were thawed and solubilized in buffer containing dodecyl maltoside. The detergent-soluble proteins were recovered following centrifugation and applied to a glutathione-agarose column. After extensive washing of the column, the transport complex was eluted either with glutathione or by incubation with the protease thrombin, which cleaves at a recognition site between the GST and MalG
sequences. We routinely observed a small amount of MalK protein in the
flowthrough of the glutathione agarose column. This is likely due to
the presence of unassociated MalK subunits in the extract. The
unassociated MalK may be the result of excess production of MalK
subunits relative to MalF and GST-MalG subunits. Although we did not
see any functional differences between the complex containing the
GST-fused MalG protein and the thrombin-cleaved complex (data not
shown), all of the experiments described in this report, unless stated
otherwise, were done with the thrombin-cleaved FGK2 complex.
As shown in lane 1 of Fig. 1A, when the
proteins are eluted by glutathione, the three complex proteins
(GST-MalG, MalF, and MalK) are the most abundant species, along with a
30-kDa species that corresponds to GST protein that is present in the
crude extract and presumably represents spontaneous cleavage of the
GST-MalG hybrid protein by endogenous proteases. As shown in lane 2, when the proteins are eluted by thrombin cleavage, the major species correspond to the MalG (28 kDa), MalF (43 kDa), and MalK (40 kDa) proteins. The amino-terminal sequence of the MalG subunit was determined by Edman degradation and was found to correspond to the
wild-type sequence plus two additional upstream amino acids, glycine
and serine, encoded as a result of the gene fusion. Figure 1B shows
Western immunoblots of the proteins bound to the column following
extensive washing (lane 1), the proteins eluted by thrombin (lane 2),
and the proteins retained on the column following thrombin cleavage
(lane 3).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and immunodetection of the purified FGK2 complex. The
FGK2 complex was purified as described in Materials and Methods. The
purified complex was then separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and transferred to
nitrocellulose membrane for immunoblotting with specific antibodies
(Ab). (A) Coomassie staining of the gel. Lanes: 1, proteins eluted by
glutathione; 2, proteins eluted by thrombin cleavage. (B)
Immunoblotting of the purified complex with specific antibodies to
GST-MalG, MalF, and MalK individually. Lanes: 1, proteins bound to the
glutathione agarose resin; 2, proteins eluted by thrombin cleavage; 3, proteins retained on the column following thrombin cleavage. The values
on the left are molecular weights (M.W.) in thousands.
|
|
ATP hydrolysis by the soluble FGK2 complex.
Although the
ATPase activity of the wild-type FGK2 complex has been studied in
detail, there is little information about its ability to hydrolyze ATP
in detergent solution. We found that the material eluted from the
glutathione agarose column exhibited very high rates of ATP hydrolysis
in the absence of MBP. In order to characterize this activity, we
measured the rates of ATP hydrolysis at different ATP concentrations
(Fig. 2). We found that the results followed a simple Michaelis-Menten type of kinetics. Double-reciprocal transformation of the data yielded values for Km
of 194 ± 10 µM and Vmax of 1,411 ± 49 nmol/min/mg. These values are similar to those reported by others
for the membrane-bound transporter when activated by liganded MBP
(11). We did not observe the cooperativity with respect to
ATP concentrations reported by Davidson et al. (7),
presumably because, as they reported, there is no cooperativity at
neutral pH. The ability of the purified maltose transporter to
hydrolyze ATP in the absence of MBP was also observed when, instead of
dodecyl maltoside, octyl glucoside was used to solubilize and purify
the complex (data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 2.
Saturation curve of ATP hydrolysis by the
detergent-soluble complex. The purified FGK2 complex (final
concentration, 5 µg/ml) was incubated in 40 mM Tris-HCl (pH 7)-4 mM
MgCl2-5% glycerol-0.01% dodecyl maltoside and various
concentrations of ATP. For each reaction, samples were removed at
various times and the amount of inorganic phosphate was determined as
described in Materials and Methods. The rates of inorganic phosphate
production were linear over the course of the reaction. The apparent
Km is 194 ± 10 µM, and the
Vmax is 1,411 ± 49 nmol/min/mg. The inset
is a plot of the first 10 data points.
|
|
Because it has been reported that the isolated MalK subunit exhibits
ATPase activity, we considered the possibility that the activity of the
detergent-soluble complex is the result of dissociation of the MalK
subunit from the MalF and MalG subunits. Two results indicate that this
explanation is highly unlikely. First, the Vmax
value of the complex is at least fivefold greater than that reported
for the isolated MalK subunit of E. coli (27).
Second, if the MalK subunit dissociates from the MalF and GST-MalG
proteins, it would not be retained if the complex is rebound to
glutathione agarose. As can be seen in Fig.
3A, when the purified detergent-soluble GST-MalGFK2 complex was dialyzed to remove glutathione, rebound to the
glutathione resin, and re-eluted, the protein profiles of the two
eluates were indistinguishable. In addition, 76% of the ATPase
activity was recovered in the second eluate (Fig. 3B). We conclude that
the MalF and MalK subunits do not dissociate from the GST-MalG subunit
in detergent solution and that the ATPase activity is due to the entire
complex.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
The GST-fused FGK2 complex does not dissociate in
detergent. A sample of the purified complex (50 µg), eluted by
glutathione from the glutathione agarose column, was dialyzed, rebound
to the column, and re-eluted. The proteins from both elutions were
assayed for ATPase activity. (A) Sodium dodecyl sulfate-polyacrylamide
gel of the first and second elutions. Lanes: 1, first elution; 2, second elution. (B) ATP hydrolysis rates of the complex.
|
|
MBP increases the activity of the purified maltose
transporter.
In whole cells, as well as in the membrane, the
ATPase and transport activities of the maltose transporter are
increased in the presence of MBP (11, 35). We have shown,
however, that the detergent-purified complex can hydrolyze ATP in the
absence of MBP. Nevertheless, the detergent-soluble form of the complex retains the ability to interact with MBP. When MBP containing maltose
is added to the complex, there is an increase of about threefold in the
rate of ATP hydrolysis (Fig. 4). This
increase is MBP specific, since addition of a signaling-defective
mutant MBP (17) resulted in a much smaller ATPase activity
increase. In addition, maltose in the absence of MBP did not affect the rate of ATP hydrolysis (data not shown). The dependence of the ATPase
activity on the concentration of MBP is similar to that reported both
in vivo (22) and in membrane vesicles (23).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 4.
Stimulation of the ATPase activity of the purified
detergent-soluble complex by the wild type but not by a
signaling-defective mutant MBP. The purified FGK2 complex was incubated
in the absence and in the presence of different concentrations of
maltose-saturated wild-type MBP or signaling-defective mutant MBP. The
ATP hydrolysis rates of the mixtures were determined as described in
legend to Fig. 2 in the presence of 4 mM ATP. Symbols: , wild-type
MBP; , signaling-defective mutant MBP.
|
|
The increase in ATP hydrolysis in the presence of MBP could result
either from a change in the affinity of the complex for ATP or a change
in the maximal rate of hydrolysis. In order to distinguish these
possibilities, we measured the rates of ATP hydrolysis by the soluble
FGK2 complex as a function of ATP concentration in the absence or
presence of 50 µM MBP containing maltose. As shown in Fig.
5, MBP mainly changes the maximal rate of
ATP hydrolysis. In the absence of MBP, the apparent
Km for ATP is 154 ± 22 µM and the
Vmax is 1,733 ± 148 nmol/min/mg, whereas
in the presence of 50 µM MBP, the apparent Km
is 143 ± 24 µM and the Vmax is
4,697 ± 1,186 nmol/min/mg. (The specific activity does not take
into account the protein contributed by the added MBP.) Thus, we
conclude that MBP does not change the affinity of the complex for ATP
but does increase the maximal rate of ATP hydrolysis. It is likely that
larger increases in the rates of ATP hydrolysis by the soluble FGK2
complex could be achieved at higher MBP concentrations. It is estimated
that in vivo, the concentration of MBP in the periplasm may reach close
to 1 mM (22). These data argue strongly that although
detergent solubilization stimulates the ATPase activity of the
transporter, the FGK2 complex interacts with and is affected by MBP in
a way that resembles the membrane-bound complex. The ability to study
the FGK2-MBP interaction and the resulting changes in conformation that
result in the activation of ATPase activity in a soluble system will
facilitate many biophysical studies.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
MBP increases the Vmax of the
ATPase activity but does not change the apparent
Km for ATP. The rate of ATP hydrolysis by the
soluble FGK2 complex was measured at different ATP concentrations (as
described in the legend to Fig. 2) in the absence and in the presence
of 50 µM maltose-saturated wild-type MBP. Symbols: , soluble FGK2
complex; , soluble FGK2 complex in the presence of 50 µM MBP. In
the absence of MBP, the apparent Km is 154 ± 22 µM and the Vmax is 1,733 ± 148 nmol/min/mg, whereas in the presence of 50 µM MBP, the apparent
Km is 143 ± 24 µM and the
Vmax is 4,697 ± 1,186 nmol/min/mg.
|
|
Davidson et al. (7) have reported that the wild-type FGK2
complex does not exhibit ATPase activity in detergent solution. In
contrast, they found that mutant complexes that do not require MBP for
transport or ATPase activity (e.g., F500GK2) did exhibit some low level
of ATPase activity in dodecyl maltoside solution. Although it is
difficult to reconcile the results presented above with those of
Davidson et al., we examined the level of ATPase activity of the
F500GK2 complex in the presence and absence of MBP. We found that the
ATPase activity of the purified F500GK2 complex in dodecyl maltoside
was higher (2,757 nmol/min/mg) than that of the wild-type complex (see
above) but that addition of even a low concentration of MBP (25 µM)
decreased the activity by 30% (1,883 nmol/min/mg). This is in marked
contrast to the effects of MBP on the ATPase activity on the wild-type
complex and closely resembles the results reported for the behavior of the F500GK2 mutant complexes in membranes (11).
The ATPase activity of the reconstituted FGK2 complex is MBP
dependent.
Several studies have shown that when the wild-type FGK2
complex is reconstituted from detergent solution, its ATPase activity is dependent on the presence of liganded MBP (7, 8). In order to test the hypothesis that either the presence of the GST moiety
fused to MalG or some other aspect of the protocol that we used to
prepare the detergent-soluble complex resulted in a permanent change in
the properties of the FGK2 complex, we studied the ATPase activity of
the soluble intact complex following reconstitution in proteoliposomes.
We reconstituted the detergent-soluble purified FGK2 complexes with
E. coli phospholipids into proteoliposomes. We compared the
ATPase activities of complexes reconstituted with and without liganded
MBP. If the GST moiety or other effects of the detergent irreversibly
changed the dependence of the complex on MBP, we would expect that even
following reconstitution into proteoliposomes, the FGK2 complex would
exhibit high rates of ATP hydrolysis with only two- to threefold
stimulation by liganded MBP. As shown in Fig.
6, the activity of the FGK2 complexes
reconstituted with liganded MBP is more than 12 times as high as the
activity of the complexes reconstituted in the absence of liganded MBP (3,026 versus 229 nmol/min/mg). These results are indistinguishable from those reported by others for the MBP dependence of ATP hydrolysis by the FGK2 complex (11). These results also indicate that
the changes produced by dodecyl maltoside that result in activation of
the ATPase are reversible upon reconstitution into proteoliposomes.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 6.
The ATPase activity of the reconstituted FGK2 complex is
MBP dependent. The purified FGK2 complex was reconstituted into
proteoliposomes (as described in Materials and Methods) in the absence
and in the presence of wild-type MBP. The reconstituted complex (final
protein concentration, 3 µg/ml) was incubated in 40 mM Tris-HCl (pH
7)-4 mM MgCl2-5% glycerol-4 mM ATP. For each reaction,
samples were removed at various times and the amount of inorganic
phosphate was determined as described in Materials and Methods.
Symbols: , reconstituted FGK2 purified complex; , reconstituted
FGK2 purified complex with wild-type MBP.
|
|
Purified MalK protein is less active than the intact complex and is
not activated by MBP.
It was shown that the MalK subunit isolated
from either Salmonella typhimurium (39) or
E. coli (27) displays ATPase activity. Although
we presented evidence that the ability of the soluble FGK2 complex to
hydrolyze ATP is not due to free MalK subunits that had dissociated
from the MalF and MalG subunits, we considered the possibility that
detergent or MBP is able to stimulate the ATPase activity of the
isolated MalK subunit. Finding that detergent stimulates the free MalK
subunit would mean that the effect of the detergent is attributable to
this subunit of the complex, and finding that MBP is able to stimulate
the ATPase activity of the isolated MalK subunit would support the
hypothesis that the ABC subunits are exposed to the periplasm and
directly interact with the ligand-binding proteins (2). In
contrast, finding that the activity of the isolated MalK subunit is not
stimulated by the MBP would support the idea that the binding protein
transmits a stimulatory signal via the integral membrane proteins that, in turn, activates ATP hydrolysis by the MalK subunits that form part
of the complex.
We expressed the His6-MalK protein as described elsewhere
(10, 30) in X90(DE3) bacteria and purified the water-soluble protein on an Ni2+ column. We then measured the rates of
ATP hydrolysis by the purified His6-MalK protein at
different ATP concentrations. The apparent Km
for ATP is 150 ± 8 µM, and the Vmax is
217 ± 15 nmol/mg/min. These characteristics are very similar to
what was reported for E. coli purified MalK protein
(27). The affinity of MalK for ATP is very similar to that
of the intact soluble complex, but the maximal rate of ATP hydrolysis
is approximately 10% of that exhibited by the intact complex.
We then asked if detergent had any effect on the rate of ATP
hydrolysis. Addition of dodecyl maltoside to the MalK protein resulted
in a 40 to 50% increase in the rate of ATP hydrolysis (from 239 to 341 nmol/min/mg). It is unlikely that this modest increase accounts for the
larger rates of hydrolysis exhibited by the intact complex in the
presence of detergent.
To examine the effect of MBP on the ability of the
His6-MalK subunit to hydrolyze ATP, we added increasing
concentrations of ligand-bound MBP to either the isolated
His6-MalK subunit or the intact detergent-soluble complex
and measured the rates of ATP hydrolysis. The results are shown in Fig.
7. It is clear that MBP has no
discernible effect on the rate of ATP hydrolysis by the
His6-MalK protein but increases the rate of the intact
complex about threefold at the highest concentration. We conclude that there is no evidence to support the idea that the MBP directly influences the activity of the His6-MalK subunit. In
contrast, these results support the hypothesis that the ligand binding
proteins transmit a signal to the integral membrane proteins that, in
turn, activate the ATPase activity of the MalK subunit.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 7.
Purified His6-MalK is not stimulated by MBP.
The purified FGK2 complex and the purified His6-MalK
protein were incubated in the absence and in the presence of different
concentrations of maltose-saturated MBP. The ATP hydrolysis rates of
the mixtures were determined as described in legend to Fig. 2. Symbols:
, detergent-soluble FGK2 complex; , His6-MalK.
|
|
FGK2 complex is inhibited by Na-azide and PCMBS.
Most ABC
transporters, including the FGK2 complex, are sensitive to inhibition
by SH-specific compounds, as well as azide, which is known to
covalently modify nucleotide binding sites. In order to find out if the
intact detergent-soluble complex resembles the membrane-bound complex
with respect to sensitivity to these compounds, we examined the effects
of a polar, membrane-impermeant mercurial,
p-chloromercuribenzosulfonic acid (PCMBS), and azide on the
ATPase activity of the intact complex. We focused on PCMBS because
preliminary results indicate that the wild-type complex is insensitive
to PCMBS in whole cells but is rapidly inactivated at low PCMBS
concentrations in everted membrane vesicles (C. Panagiotidis and M. Reyes, unpublished data). When the detergent-soluble complex was
treated with various concentrations of PCMBS, the ATPase activity was
inhibited by >95% (data not shown). Half-maximal inhibition was
observed at 25 to 50 µM. Sodium azide also inhibited the activity of
the purified complex by >90%, with half-maximal inhibition at 10 µM. Vanadate, although known to inhibit the activity of several ABC
transporters, including the membrane-bound FGK2 complex at acidic pH,
had no effect on the ATPase activity of the detergent-soluble complex
(data not shown). The inability of vanadate to inhibit the
MBP-independent F500GK2 complex at neutral pH has been previously reported (7). Vanadate may only inhibit specific
conformations of ABC transporters achieved when ADP is bound at the
nucleotide binding sites.
Verapamil increases the ATPase activity of the purified FGK2
complex and lowers its affinity for ATP.
Verapamil is a known
modulator of the activity of P-glycoprotein (15). In the
presence of 10 to 50 µM verapamil, the ATPase activity of
P-glycoprotein is increased by about 50 to 150% (3, 20,
29). Verapamil is a competitive inhibitor of P-glycoprotein (14). Recent work suggests that verapamil binds
P-glycoprotein with different affinities, probably at two different
binding sites (13, 33). Mutations that alter residues in the
hydrophobic linker region change the sensitivity of the P-glycoprotein
to verapamil and related compounds (3, 4). The same
stimulation was observed with the bacterial protein LmrA from
Lactococcus lactis, which shares a high degree of sequence
similarity with P-glycoprotein (37). Because the bacterial
importers including the FGK2 complex also have sequence similarity to
the other members of the ABC transporter family, especially surrounding
the ATP binding regions, including the hydrophobic linker region, we
wanted to find out if verapamil would have a similar effect on the
ATPase activity of the FGK2 complex. When we assayed ATP hydrolysis by the soluble intact complex in the presence of increasing concentrations of verapamil, we observed a 70 to 100% increase in the ATPase activity
of the complex at 1 to 2.5 mM (Fig. 8),
concentrations that are approximately 100-fold higher than that
required to stimulate the activity of P-glycoprotein.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 8.
Concentration-dependent stimulation of detergent-soluble
FGK2 complex ATPase activity by verapamil. The purified FGK2 complex
was assayed for ATP hydrolysis activity (as described in the legend to
Fig. 2) with 4 mM ATP in the absence and in the presence of increasing
concentrations of verapamil.
|
|
It was shown that verapamil decreases the affinity of ATP for
P-glycoprotein (34). In order to see whether verapamil
influences the affinity of the FGK2 complex for ATP or the maximal rate
of hydrolysis, we measured the rate of ATP hydrolysis by the soluble FGK2 complex as a function of ATP concentration in the absence and
presence of 1 mM verapamil. We performed these measurements several
times to get a more accurate measurement of the modest effects of
verapamil on the FGK2 ATPase activity. As summarized in Table
2, while increasing the rate of ATP
hydrolysis, verapamil lowers the affinity of the complex for ATP. Since
we saw that MBP does not influence the affinity of ATP for the complex,
it is clear that these two molecules act in different ways and probably at different sites. Although the magnitude of the stimulation by
verapamil is somewhat less than that observed for P-glycoprotein, the
fact that there is a concentration-dependent effect is likely indicative of the conservation of structure of this region among ABC
transporters. It would be interesting to know how many different types
of ABC transporters are affected by verapamil and related compounds.
 |
DISCUSSION |
ABC transporters comprise the largest single group of paralogous
proteins. Although members of this family perform a variety of
transport functions in diverse cell types, the transporters must share
common mechanisms determined by the signature ABC sequence and
similarity in overall structural organization (16). Efforts to understand the molecular basis of transport and the defects in
medically important family members, such as the P-glycoprotein responsible for multiple drug resistance in tumors and the CFTR protein, which malfunctions in individuals with cystic fibrosis, are
complicated by the complex nature of the cells and tissues in which
they function. In contrast, bacterial ABC transporters offer the
opportunity to study the mechanism of transport in simple unicellular
organism that are amenable to both biochemical and genetic analyses.
Characterization of the maltose and histidine transporters has taken
advantage of the ability to both purify the transporters and study them
genetically but is limited by the necessity to study their activities
following reconstitution in proteoliposomes. This has been based on the
observations that the detergent-soluble forms of the transporters are inactive.
Both the wild-type maltose and histidine transporters have been
reported to be inactive in detergent solution. Davidson et al. studied
a mutant form of FGK2, F500GK2, that, in contrast to the wild-type
complex, hydrolyzes ATP in the absence of MBP. They reported that the
mutant complex was able to hydrolyze ATP in detergent solution and
concluded that the mutations responsible for the uncoupled phenotype
were also responsible for the ability to retain activity in detergent
solution (7). Our results are different and clearly show
that both the wild-type and F500GK2 complexes are active in detergent
solution. Indeed, the complexes differ in their responses to MBP
signaling, with the wild type stimulated and the mutant inhibited by
MBP. These results are consistent with studies that reported the
activity of several eukaryotic ABC transporters in detergent solution
(1, 12, 25, 34).
In Table 3, we provide a summary of the
ATPase activities of the different forms of the FGK2 transporter,
including a comparison with the purified isolated MalK subunit. In
agreement with the results of others (27, 39), we found that
the isolated MalK subunit exhibited low activity that was not affected
by MBP. In addition, the membrane-bound form of the wild-type
transporter showed the same low level of activity that was stimulated
15-fold by MBP. Detergent solution of the wild-type transporter
resulted in an eightfold increase in specific activity, that could be
further increased by MBP. In contrast, as reported for membrane
preparations (11), the F500GK2 complex was more active than
the wild type in detergent solution but was inhibited by MBP. These
results indicate that the purified soluble FGK2 complex is an accurate model for studying signal transmission from MBP to the MalK subunit via
the MalFG subunits.
In addition to these results, we found that verapamil, a compound that
reverses the MDR phenotype and activates the ATPase activity of the
P-glycoprotein (15), also activates the ATPase activity of
the intact complex. We also found that, as was reported for
P-glycoprotein (34), verapamil lowers the affinity of the complex for ATP. There is some information about the sites in the
P-glycoprotein that may be important for binding of and/or stimulation
by verapamil. Alterations of sequences N terminal to the Walker B motif
appear to alter the ability of verapamil to activate the P-glycoprotein
ATPase (3, 4). It should also be possible to study the
effects of malK mutations on the ability of verapamil to
stimulate FGK2 complex ATPase activity.
With the recent appearance of the three-dimensional structure of a
related ABC transporter subunit, HisP (18), it is possible to speculate about how the membrane components and ligands control the
ability of MalK to hydrolyze ATP. Although the free MalK subunit exhibits ATPase activity, it is not stimulated by MBP. There must be an
intimate association between the MalK subunits and the MalF and MalG
subunits that can serve to activate ATP hydrolysis (26). Data presented here suggest that the activation by MBP is due not to an
increase in the affinity of the MalK subunit for ATP but to a change
that increases the rate of hydrolysis. Although we do not understand
the molecular basis of the activation of ATP hydrolysis by detergent,
we speculate that the interaction of the detergent molecules with the
membrane-spanning segments of the MalF and MalG proteins somehow
promotes conformational changes that are transmitted to the MalK
subunit. The ability to study these phenomena in solution with a
combination of genetic and biophysical methods may provide more direct
information about these proposed changes.
 |
ACKNOWLEDGMENTS |
We thank Carmen Rodriguez for excellent technical assistance.
This work was supported by award GM51118 from the National Institute
for General Medical Sciences.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, College of Physicians & Surgeons, Columbia University, 701 W. 168th St., New York, NY 10032. Phone: (212) 305-6913. Fax: (212)
305-1468. E-mail: has7{at}columbia.edu.
 |
REFERENCES |
| 1.
|
Ambudkar, S. V.,
I. H. Lelong,
J. Zhang,
C. O. Cardarelli,
M. M. Gottesman, and I. Pastan.
1992.
Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.
Proc. Natl. Acad. Sci. USA
89:8472-8476[Abstract/Free Full Text].
|
| 2.
|
Baichwal, V.,
D. Liu, and G. F. Ames.
1993.
The ATP-binding component of a prokaryotic traffic ATPase is exposed to the periplasmic (external) surface.
Proc. Natl. Acad. Sci. USA
90:620-624[Abstract/Free Full Text].
|
| 3.
|
Bakos, E.,
I. Klein,
E. Welker,
K. Szabo,
M. Muller,
B. Sarkadi, and A. Varadi.
1997.
Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region.
Biochem. J.
323:777-783.
|
| 4.
|
Beaudet, L.,
I. L. Urbatsch, and P. Gros.
1998.
Mutations in the nucleotide-binding sites of P-glycoprotein that affect substrate specificity modulate substrate-induced adenosine triphosphatase activity.
Biochemistry
37:9073-9082[CrossRef][Medline].
|
| 5.
|
Boos, W., and H. Shuman.
1998.
Maltose/maltodextrin system of Escherichia coli: transport, metabolism, and regulation.
Microbiol. Mol. Biol. Rev.
62:204-229[Abstract/Free Full Text].
|
| 6.
|
Chifflet, S.,
A. Torriglia,
R. Chiesa, and S. Tolosa.
1988.
A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases.
Anal. Biochem.
168:1-4[CrossRef][Medline].
|
| 7.
|
Davidson, A. L.,
S. S. Laghaeian, and D. E. Mannering.
1996.
The maltose transport system of Escherichia coli displays positive cooperativity in ATP hydrolysis.
J. Biol. Chem.
271:4858-4863[Abstract/Free Full Text].
|
| 8.
|
Davidson, A. L., and H. Nikaido.
1990.
Overproduction, solubilization, and reconstitution of the maltose transport system from Escherichia coli.
J. Biol. Chem.
265:4254-4260[Abstract/Free Full Text].
|
| 9.
|
Davidson, A. L., and H. Nikaido.
1991.
Purification and characterization of the membrane-associated components of the maltose transport system from Escherichia coli.
J. Biol. Chem.
266:8946-8951[Abstract/Free Full Text].
|
| 10.
|
Davidson, A. L., and S. Sharma.
1997.
Mutation of a single MalK subunit severely impairs maltose transport activity in Escherichia coli.
J. Bacteriol.
179:5458-5464[Abstract/Free Full Text].
|
| 11.
|
Davidson, A. L.,
H. A. Shuman, and H. Nikaido.
1992.
Mechanism of maltose transport in Escherichia coli: transmembrane signaling by periplasmic binding proteins.
Proc. Natl. Acad. Sci. USA
89:2360-2364[Abstract/Free Full Text].
|
| 12.
|
Doige, C. A.,
X. Yu, and F. J. Sharom.
1992.
ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.
Biochim. Biophys. Acta
1109:149-160[Medline].
|
| 13.
|
Doppenschmitt, S.,
P. Langguth,
C. G. Regardh,
T. B. Andersson,
C. Hilgendorf, and H. Spahn-Langguth.
1999.
Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
J. Pharmacol. Exp. Ther.
288:348-357[Abstract/Free Full Text].
|
| 14.
|
Ford, J. M., and W. N. Hait.
1990.
Pharmacology of drugs that alter multidrug resistance in cancer.
Pharmacol. Rev.
42:155-199[Medline].
|
| 15.
|
Gottesman, M. M., and I. Pastan.
1993.
Biochemistry of multidrug resistance mediated by the multidrug transporter.
Annu. Rev. Biochem.
62:385-427[CrossRef][Medline].
|
| 16.
|
Higgins, C. F.
1992.
ABC transporters: from microorganisms to man.
Annu. Rev. Cell Biol.
8:67-113[CrossRef].
|
| 17.
|
Hor, L. I., and H. A. Shuman.
1993.
Genetic analysis of periplasmic binding protein dependent transport in Escherichia coli. Each lobe of maltose-binding protein interacts with a different subunit of the MalFGK2 membrane transport complex.
J. Mol. Biol.
233:659-670[CrossRef][Medline].
|
| 18.
|
Hung, L. W.,
I. X. Wang,
K. Nikaido,
P. Q. Liu,
G. F. Ames, and S. H. Kim.
1998.
Crystal structure of the ATP-binding subunit of an ABC transporter.
Nature
396:703-707[CrossRef][Medline].
|
| 19.
|
Lanzetta, P. A.,
L. J. Alvarez,
P. S. Reinach, and O. A. Candia.
1979.
An improved assay for nanomole amounts of inorganic phosphate.
Anal. Biochem.
100:95-97[CrossRef][Medline].
|
| 20.
|
Litman, T.,
T. Zeuthen,
T. Skovsgaard, and W. D. Stein.
1997.
Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity.
Biochim. Biophys. Acta
1361:159-168[Medline].
|
| 21.
|
Liu, C. E., and G. F. Ames.
1997.
Characterization of transport through the periplasmic histidine permease using proteoliposomes reconstituted by dialysis.
J. Biol. Chem.
272:859-866[Abstract/Free Full Text].
|
| 22.
|
Manson, M. D.,
W. Boos,
P. J. J. Bassford, and B. A. Rasmussen.
1985.
Dependence of maltose transport and chemotaxis on the amount of maltose-binding protein.
J. Biol. Chem.
260:9727-9733[Abstract/Free Full Text].
|
| 23.
|
Merino, G.,
W. Boos,
H. A. Shuman, and E. Bohl.
1995.
The inhibition of maltose transport by the unliganded form of the maltose-binding protein of Escherichia coli: experimental findings and mathematical treatment.
J. Theor. Biol.
177:171-179[CrossRef][Medline].
|
| 24.
|
Merino, G., and H. A. Shuman.
1997.
Unliganded maltose-binding protein triggers lactose transport in an Escherichia coli mutant with an alteration in the maltose transport system.
J. Bacteriol.
179:7687-7694[Abstract/Free Full Text].
|
| 25.
|
Meyer, T. H.,
P. M. van Endert,
S. Uebel,
B. Ehring, and R. Tampe.
1994.
Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells.
FEBS Lett.
351:443-447[CrossRef][Medline].
|
| 26.
|
Mourez, M.,
M. Hofnung, and E. Dassa.
1997.
Subunit interactions in ABC transporters: a conserved sequence in hydrophobic membrane proteins of periplasmic permeases defines an important site of interaction with the ATPase subunits.
EMBO J.
16:3066-3077[CrossRef][Medline].
|
| 27.
|
Mourez, M.,
M. Jehanno,
E. Schneider, and E. Dassa.
1998.
In vitro interaction between components of the inner membrane complex of the maltose ABC transporter of Escherichia coli: modulation by ATP.
Mol. Microbiol.
30:353-363[CrossRef][Medline].
|
| 28.
|
Nikaido, K.,
P. Q. Liu, and G. F. Ames.
1997.
Purification and characterization of HisP, the ATP-binding subunit of a traffic ATPase (ABC transporter), the histidine permease of Salmonella typhimurium. Solubility, dimerization, and ATPase activity.
J. Biol. Chem.
272:27745-27752[Abstract/Free Full Text].
|
| 29.
|
Orlowski, S.,
L. M. Mir,
J. Belehradek, Jr., and M. Garrigos.
1996.
Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators.
Biochem. J.
317:515-522.
|
| 30.
|
Panagiotidis, C. H.,
W. Boos, and H. A. Shuman.
1998.
The ATP-binding cassette subunit of the maltose transporter MalK antagonizes MalT, the activator of the Escherichia coli mal regulon.
Mol. Microbiol.
30:535-546[CrossRef][Medline].
|
| 31.
|
Racker, E.,
B. Violand,
S. O'Neal,
M. Alfonzo, and J. Telford.
1979.
Reconstitution, a way of biochemical research; some new approaches to membrane-bound enzymes.
Arch. Biochem. Biophys.
198:470-477[CrossRef][Medline].
|
| 32.
|
Reyes, M., and H. A. Shuman.
1988.
Overproduction of MalK protein prevents expression of the Escherichia coli mal regulon.
J. Bacteriol.
170:4598-4602[Abstract/Free Full Text].
|
| 33.
|
Romsicki, Y., and F. J. Sharom.
1999.
The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Biochemistry
38:6887-6896[CrossRef][Medline].
|
| 34.
|
Shapiro, A. B., and V. Ling.
1994.
ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells.
J. Biol. Chem.
269:3745-3754[Abstract/Free Full Text].
|
| 35.
|
Shuman, H. A.
1982.
Active transport of maltose in Escherichia coli K12. Role of the periplasmic maltose-binding protein and evidence for a substrate recognition site in the cytoplasmic membrane.
J. Biol. Chem.
257:5455-5461[Abstract/Free Full Text].
|
| 36.
|
Silhavy, T. J.,
E. Brickman,
P. J. Bassford,
M. J. Casadaban,
H. A. Shuman,
V. Schwartz,
L. Guarente,
M. Schwartz, and J. R. Beckwith.
1979.
Structure of the malB region in Escherichia coli K12. II. Genetic map of the malE,F,G operon.
Mol. Gen. Genet.
174:249-259[CrossRef][Medline].
|
| 37.
|
van Veen, H. W.,
R. Callaghan,
L. Soceneantu,
A. Sardini,
W. N. Konings, and C. F. Higgins.
1998.
A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene.
Nature
391:291-295[CrossRef][Medline].
|
| 38.
|
Waldburger, C. D., and R. T. Sauer.
1996.
Signal detection by the PhoQ sensor-transmitter. Characterization of the sensor domain and a response-impaired mutant that identifies ligand-binding determinants.
J. Biol. Chem.
271:26630-26636[Abstract/Free Full Text].
|
| 39.
|
Walter, C.,
K. Honer zu Bentrup, and E. Schneider.
1992.
Large scale purification, nucleotide binding properties, and ATPase activity of the MalK subunit of Salmonella typhimurium maltose transport complex.
J. Biol. Chem.
267:8863-8869[Abstract/Free Full Text].
|
| 40.
|
Wiater, L. A.,
A. Marra, and H. A. Shuman.
1994.
Escherichia coli F plasmid transfers to and replicates within Legionella pneumophila: an alternative to using an RP4-based system for gene delivery.
Plasmid
32:280-294[CrossRef][Medline].
|
Journal of Bacteriology, February 2000, p. 993-1000, Vol. 182, No. 4
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Orelle, C., Ayvaz, T., Everly, R. M., Klug, C. S., Davidson, A. L.
(2008). Both maltose-binding protein and ATP are required for nucleotide-binding domain closure in the intact maltose ABC transporter. Proc. Natl. Acad. Sci. USA
105: 12837-12842
[Abstract]
[Full Text]
-
Deeley, R. G., Westlake, C., Cole, S. P. C.
(2006). Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins.. Physiol. Rev.
86: 849-899
[Abstract]
[Full Text]
-
Steinke, A., Grau, S., Davidson, A., Hofmann, E., Ehrmann, M.
(2001). Characterization of Transmembrane Segments 3, 4, and 5 of MalF by Mutational Analysis. J. Bacteriol.
183: 375-381
[Abstract]
[Full Text]